Director/PDMR Shareholding
Updated : 10:03
Immunodiagnostic Systems Holdings PLC
Director Dealing
5 July 2019
Immunodiagnostic Systems Holdings PLC ("IDS") a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces that on 3 July 2019 it granted share options ("Options") to Paul Martin, Group Finance Director, to acquire a total of 30,000 ordinary shares of 2p each in the capital of the Company under the Company's Co-Investment Executive Share Option Scheme.
The Options have been granted with an exercise price of £1.80 and subject to the satisfaction of performance conditions vest after a period of 3 years. The Options are exercisable over the period of 10 years from the date of grant.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Paul Martin, Group Finance Director |
|
|
|
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel |
|
Oliver Jackson |
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Paul Martin | ||||
2. | Reason for the notification | |||||
a. | Position/status | Group Finance Director | ||||
a. | Initial notification /Amendment | Initial | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Immunodiagnostic Systems Holdings plc | ||||
b. | LEI | 213800HZMYTD4NGF4L78 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Options over ordinary shares of 2p each in Immunodiagnostic Systems Holdings plc Ordinary shares GB00B01YZ052 | ||||
b. | Nature of the transaction | Grant of options | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information ·Aggregated volume ·Price
|
N/A
| ||||
e. | Date of the transaction | 2019-07-03 | ||||
f. | Place of the transaction | Outside trading venue - shares to be admitted to AIM market of London Stock Exchange plc on exercise of options | ||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.